# Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects

> **NCT01543490** · PHASE3 · COMPLETED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 558 (actual)

## Conditions studied

- Active, Symptomatic Blepharitis

## Interventions

- **DRUG:** ISV-305
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT01543490
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-30
- **Primary completion:** 2020-02-04
- **Final completion:** 2020-02-04
- **Target enrollment:** 558 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01543490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01543490, "Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01543490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*